A Dec. 9 report from Fitch Ratings said that insurers would shift toward market stability as the pandemic began to subside. Part of this would include the return of cost-sharing for COVID-19 patients.
Now, only a “relative handful of insurers” were still waiving cost sharing at the end of 2021, and the number continues to shrink, Cynthia Cox, a vice president at the California-based Kaiser Family Foundation, told the Star Tribune.
“The issue of cost-sharing during the pandemic raises questions about fairness,” Ms. Cox told the Star Tribune. “On one hand, if so many people are susceptible to a potentially serious viral infection, is it fair for insurers to make patients face a deductible? On the other hand, why should a cancer patient have to pay their deductible if a COVID-19 patient doesn’t?”
Sayeh Nikpay, PhD, a health economist at the University of Minnesota, told the Star Tribune that continuing to help members pay for COVID-19 care despite the widespread increase in access to vaccines and tests could create a “moral hazard” that may enable members to dismiss getting vaccinated.
However, Dr. Nikpay said that the policies will also negatively affect those who get severely ill with COVID-19 despite taking precautions.
Minnetonka, Minn.-based nonprofit payer Medica reported $83 million in COVID-19-related spending between October 2020 and September 2021, according to the Star Tribune. The payer reinstated cost-sharing Oct. 1 following an increase in the availability of vaccines.
However, among the six other nonprofit insurers in Minnesota, each is taking a different approach to cost sharing for Medicaid and Medicare beneficiaries they serve.
At the Becker's 5th Annual Fall Payer Issues Roundtable, taking place November 17–19 in Chicago, payer executives and healthcare leaders will come together to discuss value-based care, regulatory changes, cost management strategies and innovations shaping the future of payer-provider collaboration. Apply for complimentary registration now.
